These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 17467549)

  • 61. Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions.
    Wilfond BS; Parad RB; Fost N
    J Pediatr; 2005 Sep; 147(3 Suppl):S109-13. PubMed ID: 16202773
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs.
    Grosse SD; Boyle CA; Botkin JR; Comeau AM; Kharrazi M; Rosenfeld M; Wilfond BS;
    MMWR Recomm Rep; 2004 Oct; 53(RR-13):1-36. PubMed ID: 15483524
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An overview of international literature from cystic fibrosis registries 2. Neonatal screening and nutrition/growth.
    Salvatore D; Buzzetti R; Baldo E; Forneris MP; Lucidi V; Manunza D; Marinelli I; Messore B; Neri AS; Raia V; Furnari ML; Mastella G
    J Cyst Fibros; 2010 Mar; 9(2):75-83. PubMed ID: 19955022
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
    Bishop Hubbard H
    Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data.
    Lai HJ; Cheng Y; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S57-63. PubMed ID: 16202784
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening.
    Sontag MK; Corey M; Hokanson JE; Marshall JA; Sommer SS; Zerbe GO; Accurso FJ
    J Pediatr; 2006 Nov; 149(5):650-657. PubMed ID: 17095337
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Factors accounting for a missed diagnosis of cystic fibrosis after newborn screening.
    Rock MJ; Levy H; Zaleski C; Farrell PM
    Pediatr Pulmonol; 2011 Dec; 46(12):1166-74. PubMed ID: 22081556
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Diagnosis and neonatal screening of cystic fibrosis].
    Roussey M; Deneuville E; Dabadie A
    Rev Prat; 2003 Jan; 53(2):135-40. PubMed ID: 12664843
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Low-Cost and Simple Genetic Screening for Cystic Fibrosis Provided by the Brazilian Public Health System.
    Rispoli T; Martins de Castro S; Grandi T; Prado M; Filippon L; Dornelles da Silva CM; Vargas JE; Rossetti LMR
    J Pediatr; 2018 Aug; 199():272-277.e3. PubMed ID: 29731357
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [A short-term diagnostic and economic impact model of neonatal screening for cystic fibrosis].
    Rasch A; Perleth M
    Klin Padiatr; 2011 Mar; 223(2):96-103. PubMed ID: 21305445
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sweat testing infants detected by cystic fibrosis newborn screening.
    Parad RB; Comeau AM; Dorkin HL; Dovey M; Gerstle R; Martin T; O'Sullivan BP
    J Pediatr; 2005 Sep; 147(3 Suppl):S69-72. PubMed ID: 16202787
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis.
    Scotet V; de Braekeleer M; Roussey M; Rault G; Parent P; Dagorne M; Journel H; Lemoigne A; Codet JP; Catheline M; David V; Chaventré A; Duguépéroux I; Verlingue C; Quéré I; Mercier B; Audrézet MP; Férec C
    Lancet; 2000 Sep; 356(9232):789-94. PubMed ID: 11022925
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical trials in infants with cystic fibrosis detected following newborn screening.
    Stick SM
    Paediatr Respir Rev; 2008 Sep; 9(3):176-80. PubMed ID: 18694709
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Newborn screening for cystic fibrosis: evidence for benefit.
    Balfour-Lynn IM
    Arch Dis Child; 2008 Jan; 93(1):7-10. PubMed ID: 18156475
    [No Abstract]   [Full Text] [Related]  

  • 75. A product of immunoreactive trypsinogen and pancreatitis-associated protein as second-tier strategy in cystic fibrosis newborn screening.
    Weidler S; Stopsack KH; Hammermann J; Sommerburg O; Mall MA; Hoffmann GF; Kohlmüller D; Okun JG; Macek M; Votava F; Krulišová V; Balaščaková M; Skalická V; Lee-Kirsch MA; Stopsack M
    J Cyst Fibros; 2016 Nov; 15(6):752-758. PubMed ID: 27461140
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of the Quantase neonatal immunoreactive trypsinogen (IRT) screening assay for cystic fibrosis.
    Ball CL; Montgomery MD; Bridge PJ; Lyon ME
    Clin Chem Lab Med; 2005; 43(5):570-2. PubMed ID: 15899682
    [No Abstract]   [Full Text] [Related]  

  • 77. Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM
    Adv Pediatr; 2000; 47():79-115. PubMed ID: 10959441
    [No Abstract]   [Full Text] [Related]  

  • 78. [Screening tests for cystic fibrosis in the neonate].
    Shalev H; Weizman Z
    Harefuah; 1992 Apr; 122(8):508-11. PubMed ID: 1398320
    [No Abstract]   [Full Text] [Related]  

  • 79. Genetic screening as a technique of government: the case of neonatal screening for cystic fibrosis in France.
    Vailly J
    Soc Sci Med; 2006 Dec; 63(12):3092-101. PubMed ID: 16956705
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Cystic fibrosis newborn screening: management issues].
    Munck A; Roussey M
    Arch Pediatr; 2012 May; 19 Suppl 1():S30-2. PubMed ID: 22682488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.